we would like to kindly inform you that on November 30, 2020 the issue of DuoLife S.A. series C shares was closed. On February 22, 2021, the company began acquiring series D ordinary bearer shares.

For detailed information, please contact the Investor Service Office by calling 534 677 219 or via e-mail: [email protected]. We also encourage you to read the DuoLife development strategy for 2020-2025, which will bring you closer to the situation and the company's nearest plans.